Pre-treatment loss to follow-up among patients with rifampicin-resistant tuberculosis in...

Missing cases of bacteriologically confirmed TB/DR-TB from the national treatment registers in West and north Sumatra provinces, Indonesia

R Widoyo, D Djafri, ASE Putri, FF Yani… - Tropical Medicine and …, 2023 - mdpi.com

This study aimed to assess the percentage of confirmed drug-sensitive (DS) TB and drug-
resistant (DR) TB patients who were missing in the national treatment registration in North …

FAKTOR YANG MEMPENGARUHI PASIEN TUBERKULOSIS RESISTAN OBAT YANG TIDAK MEMULAI PENGOBATAN: LITERATURE REVIEW

I Rizkiyani, S Syarif - J-KESMAS: Jurnal Kesehatan …, 2024 - journal.lppm-unasman.ac.id

ABSTRAK Pasien Tuberkulosis Resistan obat (TBC RO) yang telah terdiagnosis tetapi tidak
diobati dapat menjadi sumber penularan primer dan risiko meningkatnya penularan TBC …

[PDF] 20.193.157.4

[PDF][PDF] Pre-treatment loss to follow up of tuberculosis patients; prevalence and reasons for it in central Karnataka, India.

S Ghatage, DB Shubha, S Latha, SR Kanganolli - 2022 - 20.193.157.4

Background: Pre-treatment loss to follow up (PTLFU) is defined as diagnosed TB patients
not initiated on treatment within 14 days of TB diagnosis. Bringing these PTLFU cases into …

[PDF][PDF] Pre-treatment loss to follow-up among patients with rifampicin-resistant tuberculosis in Baluchistan, Pakistan

SA Kurd, A Wali, R Fatima, A Yaqoob, D Khan, S Lehri - pdfs.semanticscholar.org

Patients with rifampicin-resistant TB (RR-TB) pretreatment loss Background: to follow-up
continue to be a global health challenge. Although the accuracy of diagnosis significantly …

[PDF][PDF] approved with reservations, 1 not approved

SA Kurd, A Wali, R Fatima, A Yaqoob, D Khan, S Lehri - 2018 - ntp.gov.pk

Patients with rifampicin-resistant TB (RR-TB) pretreatment Background: loss to follow-up
continue to be a global health challenge. Although the accuracy of diagnosis significantly …